ENTRY       D12208                      Drug
NAME        Gefurulimab (USAN)
FORMULA     C1230H1878N356O391S8
EXACT_MASS  28147.5779
MOL_WEIGHT  28164.7429
SEQUENCE    EVQLVESGGG LVKPGGSLRL SCAASGRPVS NYAAAWFRQA PGKEREFVSA INWQKTATYA
            DSVKGRFTIS RDNAKNSLYL QMNSLRAEDT AVYYCAAVFR VVAPKTQYDY DYWGQGTLVT
            VSSGGGGAGG GGAGGGGSEV QLVESGGGLV QPGGSLRLSC AASGRAHSDY AMAWFRQAPG
            QEREFVAGIG WSGGDTLYAD SVRGRFTNSR DNSKNTLYLQ MNSLRAEDTA VYYCAARQGQ
            YIYSSMRSDS YDYWGQGTLV TVSS
            (Disulfide bridge: 22-95, 160-234)
  TYPE      Peptide
EFFICACY    Anti-complement C5 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of diseases caused by complement activation
TARGET      C5 [HSA:727] [KO:K03994]
  PATHWAY   hsa04610(727)  Complement and coagulation cascades
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Complement and coagulation
                C5
                 D12208  Gefurulimab (USAN)
DBLINKS     CAS: 2456407-94-4
///
